Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia

Published:2013-10 Issue: Volume:79 Page:304-312
ISSN:1053-8119
Container-title:NeuroImage
language:en
Short-container-title:NeuroImage

Author:

Ceccarini Jenny,De Hert Marc,Van Winkel Ruud,Peuskens Joseph,Bormans Guy,Kranaster Laura,Enning Frank,Koethe Dagmar,Leweke F. Markus,Van Laere Koen

Publisher

Elsevier BV

Subject

Cognitive Neuroscience,Neurology

Reference55 articles.

1. Diagnostic and Statistical Manual of Mental Disorders;American Psychiatry Association,2000

2. Feasibility of central cannabinoid CB1 receptor imaging with [124I]AM281 PET demonstrated in a schizophrenic patient;Berding;Psychiatry Res.,2006

3. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor;Burns;Proc. Natl. Acad. Sci. U. S. A.,2007

4. A neurobiological basis for substance abuse comorbidity in schizophrenia;Chambers;Biol. Psychiatry,2001

5. The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families;Cornblatt;Psychiatry Res.,1988

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic‐like activity of cannabidiolic acid methyl ester in the MK‐801 mouse model of schizophrenia: Role for cannabinoid CB1 and serotonin‐1A receptors;European Journal of Neuroscience;2024-02-22

2. In silico analyses of the involvement of GPR55, CB1R and TRPV1: response to THC, contribution to temporal lobe epilepsy, structural modeling and updated evolution;Frontiers in Neuroinformatics;2024-02-07

3. Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review;Pharmacopsychiatry;2024-01-24

4. Emerging therapeutic role of cannabis in neurological disorders;Cannabis and Derivatives;2024

5. Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: A pilot study;Neurobiology of Disease;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3